Patents
Patents for C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041)
05/2011
05/11/2011EP2319848A1 2,2'-Di (3,4-alkylenedioxythiophene) derivatives and their use for the preparation of 2,2'-Poly-(3,4-alkylendioxythiophene)-Derivatives
05/11/2011EP2319847A2 Diazabenzo[de]anthracen-3-one compounds and methods for inhibiting PARP
05/11/2011EP2318415A1 Oxazolopyrimidines as edg-1 receptor agonists
05/11/2011EP2318407A1 Pyrazolopyridine kinase inhibitors
05/11/2011EP2318403A1 Aryl- and heteroarylcarbonyl derivatives of substituted nortropanes, medicaments containing such compounds and their use
05/11/2011CN102056899A Polycyclic compound and organic electroluminescent device using the same
05/11/2011CN102050832A Melonines bisindole compound, medicine composition, preparation method and application thereof
05/11/2011CN102050831A Cephalosporin derivative
05/10/2011CA2519063C Immunomodulating heterocyclic compounds
05/10/2011CA2473572C Quinazoline compounds
05/05/2011WO2011052702A1 Polymeric compound and electronic element
05/05/2011WO2011051478A1 Novel oxime derivatives and their use as allosteric modulators of metabotropic glutamate receptors
05/05/2011WO2011051452A1 N-containing heteroaryl derivatives as jak3 kinase inhibitors
05/05/2011US20110105427 Deazapurines and uses thereof
05/05/2011US20110101312 Deuterated compounds for electronic applications
05/05/2011CA2779105A1 Kinase inhibitors
05/05/2011CA2779073A1 Novel oxime derivatives and their use as allosteric modulators of metabotropic glutamate receptors
05/05/2011CA2778680A1 N-containing heteroaryl derivatives as jak3 kinase inhibitors
05/05/2011CA2778615A1 Methods of synthesis and purification of heteroaryl compounds
05/04/2011EP1730146B1 Azaindoles useful as inhibitors of jak and other protein kinases
05/04/2011EP1551412B1 Pharmaceutical compositions for the treatment of diseases related to neurotrophines
05/04/2011CN102040616A Preparation method of cefozopran hydrochloride
05/04/2011CN101555253B Ruthenium polypyridyl complex inducing DNA to condense, preparation method and application thereof
04/2011
04/28/2011US20110098277 Fab I Inhibitors
04/27/2011EP2314571A2 Carbamoyl esters that inhibit cholinesterase and release pharmacologically active agents
04/27/2011EP2313408A1 Diketopiperidine derivatives as hiv attachment inhibitors
04/27/2011EP2313407A1 cMET INHIBITORS
04/27/2011EP2313406A2 4-dimethylaminophenyl substituted napththyridines und their use as medicine
04/27/2011EP1951724B1 FUSED BICYCLIC mTOR INHIBITORS
04/27/2011EP1709052B1 Derivatives of 1,4-diazabicyclo 3.2.1octanecarboxamide, preparation method thereof and use of same in therapeutics
04/27/2011CN102036997A Fused pyrazine compounds useful for the treatment of degenerative and inflammatory diseases
04/27/2011CN102036992A Switchable special effect substances
04/27/2011CN102030766A Flomoxef antibiotic containing pyrrolinheterocycle
04/27/2011CN102030765A Ether-linked porphyrin dimer salt and preparation method thereof
04/27/2011CN102030750A Novel tetrahydro-1H-pyrido [4,3-b] indole derivatives as CB1' receptor ligands
04/27/2011CN101497622B Pyridine methyl sulfinyl imidazopyridine derivative
04/27/2011CN101323616B Carbpenem derivates containing sulfhydryl thiazole
04/26/2011US7932259 Pyrrolo[2,3-d]pyrimidine derivatives substituted with a cyclic amino group
04/26/2011US7932251 6-phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivatives
04/26/2011CA2462657C Staurosporine derivatives as inhibitors of flt3 receptor tyrosine kinase activity
04/21/2011WO2011012896A3 Spirocyclic amide derivatives
04/20/2011EP2311842A2 PI3K/M TOR inhibitors
04/20/2011EP2311837A1 Azaindoles useful as inhibitors of jak and other protein kinases
04/20/2011EP2310395A1 9-substituted-b-carboxy-oxadiazino-quinolone derivatives, their preparation and their application as anti-bacterials
04/20/2011EP2310381A1 2,4'-bipyridinyl compounds as protein kinase d inhibitors useful for the treatment of ia heart failure and cancer
04/20/2011EP2310019A2 5-ht3 receptor modulators, methods of making, and use thereof
04/20/2011EP1976853B1 Novel compounds and use thereof
04/20/2011EP1517908B1 Novel benzimidazole derivatives
04/20/2011EP1399161B1 Sustained-release analgesic compounds
04/20/2011CN102020643A dihydropteridine ketone derivative, and preparation method and medicinal application thereof
04/20/2011CN101314595B Aromatic hydrocarbons connected multi-polyamine large-ring derivants, preparation method and medical use thereof
04/19/2011US7928231 Thienopyrazoles
04/19/2011CA2393802C 3-aminoquinazolin-2,4-dione antibacterial agents
04/14/2011US20110085985 Novel substituted azabenzoxazoles
04/13/2011EP2308877A1 Imidazopyridin-2-on derivative
04/13/2011EP2308562A2 Azetidine ring compounds and drugs comprising the same
04/13/2011EP2307426A1 Fused pyrazine compounds useful for the treatment of degenerative and inflammatory diseases
04/13/2011EP2307416A2 Substituted tricyclic derivatives against neurodegenerative diseases
04/13/2011EP2215095B1 Cyclopropyl fused indolobenzazepine derivatives for the treatment of hepatitis c
04/13/2011EP2018165B1 Fgf-peceptor agonist dimeric compounds
04/13/2011CN102017218A Organic electroluminescent element
04/13/2011CN102015710A Azatricyclic antibiotic compounds
04/13/2011CN102015703A Compound having pyridoindole ring structure bonded with substituted pyridyl group, and organic electroluminescent device
04/13/2011CN102015698A Oxazolidinone derivatives
04/13/2011CN102010422A Guanidyl-containing artemisinin derivates and application thereof
04/13/2011CN102010414A Heterocyclic compound and organic light-emitting device and panel display device including same
04/13/2011CN102010410A Heterocyclic compound and organic light emitting device including same
04/12/2011US7923454 morphinan's such as 3-methoxy-17-allylmorphinan hydrobromide used for preventing or treating viral infections, septic shock, organ damage, neurological and cardiovascular disorders, neurodegenerative diseases and cancers
04/06/2011EP2305684A1 Poycyloalkylpurines as adenosine receptor antagonists
04/06/2011EP2305677A1 Alkyne-aryl-naphthyridin-4(1h)-one derivatives as type IV phosphodiesterase inhibitor
04/06/2011EP2303893A1 Tricyclic indole derivatives and methods of use thereof
04/06/2011EP2303876A1 Diketo azolopiperidines and azolopiperazines as anti-hiv agents
04/06/2011CN102007128A Tricyclic antibiotics
04/06/2011CN102007124A Pyrimidine-2-amine compounds and their use as inhibitors of jak kinases
04/06/2011CN102002060A Preparation method of cefozopran hydrochloride
04/06/2011CN102002046A Organic light emitting device
03/2011
03/31/2011WO2011038293A1 Cyclic peptide inhibitors of hepatitis c virus replication
03/31/2011WO2011036889A1 Heterocyclic compound
03/31/2011WO2011036576A1 Gpr 119 modulators
03/31/2011WO2011036461A1 Fused imidazo [3, 2 - d] pyrazines as pi3 kinase inhibitors
03/31/2011WO2011036280A1 Benzoxazepin pi3k inhibitor compounds and methods of use
03/31/2011WO2011035534A1 Dihydropteridinone derivatives, preparation process and pharmaceutical use thereof
03/31/2011WO2011035417A1 Hsp-90 binding compounds, compositions thereof, and their use fn the treatment of autoimmune and inflammatory diseases
03/31/2011US20110077266 Diamine Derivatives
03/31/2011CA2775697A1 Cyclic peptide inhibitors of hepatitis c virus replication
03/31/2011CA2775204A1 Fused imidazo [3, 2 - d] pyraz ines as pi3 kinase inhibitors
03/31/2011CA2774731A1 Dihydropteridinone derivatives, preparation process and pharmaceutical use thereof
03/31/2011CA2772691A1 Benzoxazepin pi3k inhibitor compounds and methods of use
03/31/2011CA2772188A1 Gpr 119 modulators
03/30/2011EP2301936A1 Spirodiamine-diarylketoxime derivative
03/30/2011EP2301921A1 Polycyclic compound and organic electroluminescent device using the same
03/30/2011EP2300485A1 Pyrrolo ý2, 3-c¨pyridine derivatives as p38 kinase inhibiting agents
03/30/2011EP2300481A2 Novel substituted azabenzoxazoles
03/30/2011EP1940835B1 Pyrazolo[3,4-b]pyridine compounds, and their use as pde4 inhibitors
03/30/2011EP1558586B1 Inhibitors of akt activity
03/30/2011CN101998958A Thieno-and furo-pyrimidine modulators of the histamine h4 receptor
03/30/2011CN101993448A Anti-mycobacteria oxazolidinones used for treating infectious disease
03/30/2011CN101993409A Heterocyclic compound, organic light-emitting device containing polycyclic heteroaryl compounds
03/29/2011US7915280 Compounds and their uses
03/29/2011US7914706 Charge transport compositions and electronic devices made with such compositions
1 ... 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 ... 111